Schneeweiss, A., Marmé, F., Ruiz, A., Manikhas, A. G., Bottini, A., Wolf, M., . . . Bauknecht, T. (2011). A randomized phase II trial of doxorubicin plus pemetrexed followed by docetaxel versus doxorubicin plus cyclophosphamide followed by docetaxel as neoadjuvant treatment of early breast cancer. Annals of oncology, 22(3), . https://doi.org/10.1093/annonc/mdq400
Chicago-Zitierstil (17. Ausg.)Schneeweiss, Andreas, et al. "A Randomized Phase II Trial of Doxorubicin Plus Pemetrexed Followed by Docetaxel Versus Doxorubicin Plus Cyclophosphamide Followed by Docetaxel as Neoadjuvant Treatment of Early Breast Cancer." Annals of Oncology 22, no. 3 (2011). https://doi.org/10.1093/annonc/mdq400.
MLA-Zitierstil (9. Ausg.)Schneeweiss, Andreas, et al. "A Randomized Phase II Trial of Doxorubicin Plus Pemetrexed Followed by Docetaxel Versus Doxorubicin Plus Cyclophosphamide Followed by Docetaxel as Neoadjuvant Treatment of Early Breast Cancer." Annals of Oncology, vol. 22, no. 3, 2011, https://doi.org/10.1093/annonc/mdq400.